BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 34384783)

  • 1. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.
    Chaurasia P; Nguyen THO; Rowntree LC; Juno JA; Wheatley AK; Kent SJ; Kedzierska K; Rossjohn J; Petersen J
    J Biol Chem; 2021 Sep; 297(3):101065. PubMed ID: 34384783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
    Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
    Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR.
    Szeto C; Nguyen AT; Lobos CA; Chatzileontiadou DSM; Jayasinghe D; Grant EJ; Riboldi-Tunnicliffe A; Smith C; Gras S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X; Chen G; Weng NP; Mariuzza RA
    J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal SARS-CoV-2-specific CD8
    Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.
    Bovay A; Zoete V; Dolton G; Bulek AM; Cole DK; Rizkallah PJ; Fuller A; Beck K; Michielin O; Speiser DE; Sewell AK; Fuertes Marraco SA
    Eur J Immunol; 2018 Feb; 48(2):258-272. PubMed ID: 28975614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8
    Song I; Gil A; Mishra R; Ghersi D; Selin LK; Stern LJ
    Nat Struct Mol Biol; 2017 Apr; 24(4):395-406. PubMed ID: 28250417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity.
    Wu D; Efimov GA; Bogolyubova AV; Pierce BG; Mariuzza RA
    J Biol Chem; 2023 Apr; 299(4):103035. PubMed ID: 36806685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A
    Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
    Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.
    Cole DK; Yuan F; Rizkallah PJ; Miles JJ; Gostick E; Price DA; Gao GF; Jakobsen BK; Sewell AK
    J Biol Chem; 2009 Oct; 284(40):27281-9. PubMed ID: 19605354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of T cell receptor specificity and cross-reactivity of two HLA-DQ2.5-restricted gluten epitopes in celiac disease.
    Ciacchi L; Farenc C; Dahal-Koirala S; Petersen J; Sollid LM; Reid HH; Rossjohn J
    J Biol Chem; 2022 Mar; 298(3):101619. PubMed ID: 35065967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection establishes a stable and age-independent CD8
    Choy C; Chen J; Li J; Gallagher DT; Lu J; Wu D; Zou A; Hemani H; Baptiste BA; Wichmann E; Yang Q; Ciffelo J; Yin R; McKelvy J; Melvin D; Wallace T; Dunn C; Nguyen C; Chia CW; Fan J; Ruffolo J; Zukley L; Shi G; Amano T; An Y; Meirelles O; Wu WW; Chou CK; Shen RF; Willis RA; Ko MSH; Liu YT; De S; Pierce BG; Ferrucci L; Egan J; Mariuzza R; Weng NP
    Nat Commun; 2023 Oct; 14(1):6725. PubMed ID: 37872153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of highly cytotoxic CD8
    Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
    Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
    Knutson KL; Disis ML
    Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
    Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
    PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
    Wang YD; Sin WY; Xu GB; Yang HH; Wong TY; Pang XW; He XY; Zhang HG; Ng JN; Cheng CS; Yu J; Meng L; Yang RF; Lai ST; Guo ZH; Xie Y; Chen WF
    J Virol; 2004 Jun; 78(11):5612-8. PubMed ID: 15140958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.